-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
SAB Biotherapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2024.
- SAB Biotherapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was -110 %, a 25% decline year-over-year.
- SAB Biotherapeutics, Inc. annual Return On Equity for 2023 was -145 %, a 170% decline from 2022.
- SAB Biotherapeutics, Inc. annual Return On Equity for 2022 was -53.5 %, a 19.1% decline from 2021.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)